評論
打印
Former Novartis CEO Joe Jimenez met with Trump in late January 2017.
2017年1月底，諾華集團(tuán)前CEO江慕忠曾見過特朗普。
Starting in February that year,
從那年二月開始，
the company paid Essential Consultants $100,000 a month for services focused on “U.S. health care policy matters.”
諾華集團(tuán)每月都會支付“必要咨詢”10萬美元，購買“美國的服務(wù)醫(yī)療政策事務(wù)”方面的服務(wù)。
After Novartis executives met with Cohen in March,
今年3月，諾華高管與科恩會面后，
the company “determined that Michael Cohen and Essentials Consultants would be unable to provide the services that Novartis had anticipated,”
該公司“發(fā)現(xiàn)，邁克爾·科恩和‘必要咨詢’并不能提供他們預(yù)期的服務(wù)，”
a spokesman said on May 9.
一位發(fā)言人在5月9日說到。
Novartis nevertheless kept up the payments for a full year, until the contract expired.
盡管如此，諾華還是堅持支付了整整一年的費(fèi)用，直到合同到期。
What, if anything, it received in return is unclear.
它得到了什么回報，如果有得到回報的話，還不清楚。
Last year, the FDA approved Rydapt, a mast cell disorder and leukemia drug,
去年，F(xiàn)DA批準(zhǔn)了Rydapt這種治療肥大細(xì)胞紊亂和白血病的藥物，
and the Centers for Medicare and Medicaid Services approved limited reimbursements for its rare-blood-cancer drug, Kymriah,
醫(yī)療保險和醫(yī)療補(bǔ)助服務(wù)中心也批準(zhǔn)了對其罕見血癌藥物Kymriah發(fā)放一定補(bǔ)助的申請，
which runs $475,000 for a course of a treatment.
而這種藥物一個療程的費(fèi)用就高達(dá)47.5萬美元。
Incoming chief executive Vasant Narasimhan was also invited to an exclusive sit-down dinner
2018年1月達(dá)沃斯世界經(jīng)濟(jì)論壇期間，
with Trump at the World Economic Forum in Davos in January 2018.
即將上任的新任諾華CEO瓦桑特·納拉西姆漢也受邀和特朗普一起出席某獨(dú)家晚宴。
On May 9, the company confirmed that its arrangement with Essential Consultants has attracted the attention of Mueller’s team,
5月9日，該公司證實(shí)，其與“必要咨詢”的約定已經(jīng)引起了穆勒團(tuán)隊的注意，
which questioned the company over its payments to Cohen.
后者對該公司向科恩支付的那些款項存疑。
“In hindsight, this must be seen as a mistake,” Novartis spokesman Michael Willi told Reuters.
“事后看來，這必須被視為一個錯誤，”諾華發(fā)言人邁克爾·威力在接受路透社采訪時表示。
Perhaps most intriguing, though, are the $500,000 in payments to Essential Consultants from Columbus Nova,
也許，那些款項中最有趣的要數(shù)哥倫布諾瓦公司給“必要咨詢”的那50萬美元了，
a New York investment firm whose biggest client is the Renova Group,
哥倫布諾瓦是紐約的一家投資公司，其最大的客戶是列諾瓦集團(tuán)，
which is, in turn, controlled by the Russian oligarch Viktor Vekselberg.
而后者的控制權(quán)掌握在俄羅斯寡頭維克托·維克塞爾伯格的手里。
Vekselberg and Renova are both under U.S. sanctions imposed in retaliation for Russia’s meddling in the 2016 election.
維克塞爾伯格和列諾瓦目前都在美國的制裁名單上，美國此舉則是為了報復(fù)俄羅斯干預(yù)2016年美國大選一事。
Earlier this year, investigators with special counsel Mueller
據(jù)報道，今年早些時候，調(diào)查人員就和特別檢察官穆勒
reportedly questioned Vekselberg about his investments in Columbus Nova’s private equity funds.
針對維克塞爾伯格在哥倫布諾瓦公司的私募股權(quán)基金中的投資傳問了后者。
譯文由可可原創(chuàng)，僅供學(xué)習(xí)交流使用，未經(jīng)許可請勿轉(zhuǎn)載。
